DSCSA Product Tracing and T3 Documentation Inspection

It covers the record set needed to verify product tracing for covered prescription drugs: transaction information, transaction statements, T3 completeness, storage and access controls, exception handling, and final sign-off. The template is built to check whether the product identifier, lot number, and transaction date match the physical or electronic record trail. It also captures whether missing or discrepant elements were escalated and resolved. Use it as an audit-ready review of both documents and the controls around them.

Use it during routine compliance audits, onboarding of a new trading partner, post-receipt verification, or after a discrepancy involving suspect product or missing documentation. It is also useful when you want to sample inbound and outbound transactions for a defined inspection period. If you are investigating a single shipment issue, you can narrow the scope to that lot or transaction date range. If you need a broader quality-system review, expand the sample set across multiple product lines and locations.

A compliance lead, quality manager, pharmacy operations manager, or other responsible person with access to DSCSA records should run it. The reviewer should understand transaction data, record retention rules, and the internal escalation path for discrepancies. If the inspection is part of a formal audit, include a second reviewer or management sign-off. The template also works well when a receiving supervisor performs the first-pass check and compliance validates the findings.

The cadence depends on your risk profile and transaction volume, but most organizations use it on a scheduled basis and after any exception involving missing or mismatched data. High-volume distributors and pharmacies often review samples monthly or quarterly, then perform targeted checks when a trading partner changes systems or formats. If you have recurring discrepancies, increase the frequency until the root cause is corrected. The template supports both recurring audits and event-driven reviews.

The template is aligned to DSCSA product tracing expectations and the FDA's broader focus on transaction information, transaction statements, and chain-of-custody continuity. It helps document whether the required data elements are present, legible, and traceable through prior ownership or distribution events. It also supports controlled handling of suspect product and exception documentation. Use it as an operational record, not as a substitute for legal review of your specific obligations.

Common findings include missing product identifiers, lot numbers that do not match source documents, incomplete transaction statements, and records stored in locations that are not access-controlled. Teams also miss gaps in traceability when a prior ownership event cannot be tied back cleanly, or when exceptions are logged without an owner and due date. Another frequent issue is premature deletion or overwriting of records before the retention period ends. The template is designed to surface those failures quickly.

Yes. You can tailor the inspection period, product scope, sampling method, and escalation fields to match your distribution model, pharmacy workflow, or ERP setup. Many teams add fields for trading partner name, internal shipment reference, scan source, or quarantine location. If you need to align with a specific internal SOP, keep the core DSCSA checks intact and add only the extra fields you actually use. That keeps the inspection usable and avoids turning it into a generic checklist.

Ad-hoc checks usually catch only obvious missing paperwork, while this template forces a repeatable review of completeness, traceability, storage control, and exception closure. That makes it easier to compare results across sites, reviewers, and time periods. It also creates a defensible record of what was reviewed and what was escalated. If you need audit trail continuity, a structured template is much stronger than a one-off email or spreadsheet note.

Yes. The template works well alongside ERP, WMS, serialization platforms, and document repositories because it references the fields reviewers already pull from those systems. You can add links or record IDs for source documents, scan logs, or quarantine records. The key is to preserve the inspection evidence and resolution status in one place. That way, the inspection becomes a traceable control rather than a separate manual log.